E5103 On-Study Form NCT00433511 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Source Form: NCI FormBuilder:

  1. 8/26/12 8/26/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 6/16/15 6/16/15 -
  4. 9/20/21 9/20/21 -
Uploaded on:

September 20, 2021

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

E5103 On-Study Form NCT00433511

Instructions: Complete this form and submit original to the ECOG Coordinating Center within one week of registrations. Keep a copy for your files.

ECOG clinical trial administrative data
Reporting Period
Patient demographics
Performance status
ECOG Performance Status (Day 1 of this cycle)
Menopausal status (Definitions of Menopausal Status: Postmenopausal: Defined as at least one of the following: 1 age >55 with no spontaneous menses for at least 12 months; or 2 age </=55 with no spontaneous menses within the past 12 months e.g., spontaneously or...)
Pre-registration Evaluation
Prior tamoxifen therapy
Prior raloxifene therapy? (for chemoprevention)
Pre-registration Scans/imaging
Method of Evaluation
Disease Description
Tumor Laterality (NOTE: Submit copies of pathology reports for all diagnostic and therapeutic surgical procedures with E5103 Source Document Tracking Coversheet)
Breast: Surgical Procedures
Most Extensive Primary Surgery
Was sentinel node sampling performed
Was axillary dissection performed?
Breast: Disease Description
Histologic Grade (For breast cancer, a combined histologic grade is used according to SBR/Elston classification)
Nuclear Grade
Receptor Status, ER (as defined by local laboratory; borderline results should be reported as positive)
Receptor Status, PgR
Her2/neu expression status by immunohistochemistry (DAKO HercepTest)
Breast: Surgical Procedures
Breast: Disease Description
Footer Module

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial